BLRX 株価推移チャート
BLRX 財務
BioLineRx Ltd.
$3.1
-7.46%
$-0.25
終値： May 07, 16:00:00 GMT-4
$3.1
0%
$0
アフターマーケット：May 07, 20:00:00 GMT-4
戻る
BioLineRx Ltd. (BLRX) 財務
主要データ
前終値
$3.35
始値
$3.29
当日レンジ
$3.1 - $3.33
52週レンジ
$2.15 - $7.77
取引高
13.5K
平均取引高
18.3K
配当利回り
--
1株当たり利益(TTM)
0.00
時価総額
$13.4M
BioLineRx Ltd.とは何ですか？
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
